These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6367168)

  • 1. Liver transplantation followed by high-dose cyclophosphamide, total-body irradiation, and autologous bone marrow transplantation for treatment of metastatic breast cancer. A case report.
    Huber C; Niederwieser D; Schönitzer D; Gratwohl A; Buckner D; Margreiter R
    Transplantation; 1984 Mar; 37(3):311-2. PubMed ID: 6367168
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor recurrence after liver transplantation followed by high-dose cyclophosphamide, total body irradiation, and autologous bone marrow transplantation for treatment of metastatic liver disease.
    Margreiter R; Niederwieser D; Frommhold H; Schönitzer D; Gratwohl A; Huber C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2403-4. PubMed ID: 3079082
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Kennedy MJ; Anderson LW; Kiraly SB; Black KC; Colvin OM; Grochow LB
    Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
    Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
    Transplantation; 2000 May; 69(10):2043-8. PubMed ID: 10852594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy.
    Shah AB; Hartsell WF; Ghalie R; Kaizer H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1433-8. PubMed ID: 7635784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma.
    Saez RA; Slease RB; Selby GB; Strnad C; Epstein RB; Confer DL
    South Med J; 1995 Mar; 88(3):320-6. PubMed ID: 7886530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
    Demirer T; Buckner CD; Appelbaum FR; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger WI
    Bone Marrow Transplant; 1996 May; 17(5):769-74. PubMed ID: 8733696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation.
    Ghalie R; Richman CM; Adler SS; Cobleigh MA; Korenblit AD; Manson SD; McLeod BC; Taylor SG; Valentino LA; Wolter J
    J Clin Oncol; 1994 Feb; 12(2):342-6. PubMed ID: 8113841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.
    Livingston RB; Schulman S; Griffin BR; Tranum BL; Rivkin SE; Goldberg RS; Fabian CJ; Hammond N; Hynes H
    Cancer; 1987 Apr; 59(7):1249-54. PubMed ID: 3545430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
    Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
    Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
    [No Abstract]   [Full Text] [Related]  

  • 13. Total body irradiation and autologous bone-marrow infusion for relapsed acute leukaemia.
    Kelly SJ; Bunch C; Potter CG
    Lancet; 1986 Apr; 1(8484):799. PubMed ID: 2870289
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB
    Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow.
    Phillips GL; Herzig RH; Lazarus HM; Fay JW; Wolff SN; Mill WB; Lin H; Thomas PR; Glasgow GP; Shina DC
    N Engl J Med; 1984 Jun; 310(24):1557-61. PubMed ID: 6374452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose cyclophosphamide and whole-body radiotherapy followed by bone marrow transplant in patients with leukemia].
    Fernández-Rañada JM; Vázquez L; Lozano M; Fernández-Garese D; Figuera A; Arranz R; González N; Gómez N; Fernández Villalta MJ; Gómez-Reino F
    Rev Clin Esp; 1987 Mar; 180(5):247-52. PubMed ID: 3299537
    [No Abstract]   [Full Text] [Related]  

  • 17. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas.
    Ghalie R; Richman CM; Adler SS; Korenblit AD; Kramer TS; Manson S; Dolce A; Kaizer H
    Bone Marrow Transplant; 1991 Jul; 8(1):41-5. PubMed ID: 1912954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.
    Dunbar CE; Nienhuis AW; Stewart FM; Quesenberry P; O'Shaughnessy J; Cowan K; Cottler-Fox M; Leitman S; Goodman S; Sorrentino BP
    Hum Gene Ther; 1993 Apr; 4(2):205-22. PubMed ID: 8098622
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes.
    Crump M; Goss PE; Prince M; Girouard C
    J Clin Oncol; 1996 Jan; 14(1):66-9. PubMed ID: 8558222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.